New FDA Enforcement Memo Clears Way For Hemp CBD Product Coverage Under New Medicare Plan
The Food and Drug Administration (FDA) has issued guidance making clear that it does not intend to interfere with implementation of a new Trump administration initiative to cover up to $500 worth of hemp-derived products each year for eligible Medicare patients. FDA Commissioner Marty Makary wrote in a two-page memo on Wednesday that the agency […]
White House Schedules More Meetings On Cannabis Product Enforcement Policy From FDA For This Week
The White House now scheduled a total of four meetings with cannabis industry and research stakeholders this week to discuss a proposed enforcement policy for CBD products. The Office of Information and Regulatory Affairs (OIRA) under the White House Office of Management and Budget (OMB) announced earlier this month that it plans to review yet-unpublished guidance […]
Congress will consider hemp THC product ban delay next week (Newsletter: February 25, 2026)
VA marijuana sales bill; OR medical cannabis in hospices; FL medical marijuana for vets; Psychedelic legalization poll; Op-ed calling out NYT’s stance Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day. Your support makes Marijuana Moment possible… […]
FDA Faces Deadline To Publish Cannabinoid Lists And Define Hemp Product ‘Containers’ Under Law Trump Signed
In about nine months, federal hemp laws are scheduled to significantly change in a way that industry stakeholders say would effectively upend the market by re-criminalizing most consumable cannabinoid products. But in the interim, the Food and Drug Administration (FDA) is facing a deadline next week to help inform future hemp policy. As part of […]